Lv11
40 积分 2025-06-19 加入
Clinicogenomic determinants of early progression on first-line osimertinib in EGFR-mutant NSCLC
10分钟前
待确认
Comparison of circulating tumor DNA assays for molecular residual disease detection in non-small cell lung cancer
2个月前
已完结
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
5个月前
已完结
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer
5个月前
已完结
Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multi-Center Retrospective Study
9个月前
已完结
Analysis of the efficacy and influencing factors of double-dose furmonertinib for advanced EGFR ex20ins non-small cell lung cancer
1年前
已完结
Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Resectable Non–small Cell Lung Cancer Treated With Neoadjuvant Immunotherapy Plus Chemotherapy
1年前
已完结
Thoracic sarcopenia was a poor prognostic predictor in patients receiving immunotherapy retain-->for advanced non-small-cell retain-->lung cancer
1年前
已完结
The Prognostic Value of Baseline 18F-FDG PET/CT in Stage IV Non–Small Cell Lung Cancer Patients Receiving Osimertinib Treatment
1年前
已关闭
Comparison of short- and long-term outcomes in patients undergoing sleeve lobectomy with or without buttressing the bronchial anastomosis
1年前
已完结